Stemina marks big advance with EPA contract

A $10.6 million, five-year EPA contract for Stemina Biomarker Discovery, announced this week, doesn’t just provide a new source of revenue. It also holds the potential to make the Madison company’s technology a standard for testing chemicals and drugs for their toxic effects, long-term, CEO Elizabeth Donley said.Read more

Comments are closed.